Fortune: A $200 debit card won’t put a dent in seniors’ drug costs

Policy experts say that what Medicare beneficiaries really need are sweeping federal changes to close the gap between what their health insurance pays and what drugs cost them. PAN Foundation President and CEO Dan Klein comments on how the Trump administration’s proposal to provide $200 debit cards to seniors would be better served focusing on people with serious illnesses who have high out-of-pocket drug costs.